Top 3 Genomic Sequencing Stocks to Buy on the Rebound
While COVID-19 has taken center stage for the past year, there remains a huge need for advance testing, treatment options and cures for other diseases. That points toward personalized medicine and next-generation genomic sequencing (NGS) solutions.
There are many players in the sequencing market, each of which offers a different twist and exposure for investors.